 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper131st MAINE LEGISLATURE
FIRST SPECIAL SESSION-2023
Legislative Document No. 1467
S.P. 586 In Senate, April 5, 2023
An Act to Establish the Maine Cannabis Research Committee and 
Facilitate Research into Alternative Therapeutics
Reference to the Committee on Health and Human Services suggested and ordered printed.
DAREK M. GRANT
Secretary of the Senate
Presented by Senator BRAKEY of Androscoggin.
Cosponsored by Representatives: BOYLE of Gorham, MATHIESON of Kittery, O'NEIL of 
Saco.

Page 1 - 131LR1683(01)1Be it enacted by the People of the State of Maine as follows:
2Sec. 1.  5 MRSA ยง12004-I, sub-ยง31-C is enacted to read:
331-C.  
 Health Care  Maine Cannabis Research Committee $1,000 after first 
6 meetings in a 
calendar year and 
an additional 
$1,000 after 6 
meetings in the 
same calendar 
year 22 MRSA 
ยง2700-F
4Sec. 2.  22 MRSA c. 607 is enacted to read:
13CHAPTER 607
14CANNABIS RESEARCH COMMITTEE
15ยง2700-F. Maine Cannabis Research Committee
161. Committee established as a public instrumentality. The Maine Cannabis 
17 Research Committee, as established by Title 5, section 12004-I, subsection 31-C and 
18 referred to in this section as "the committee," is established as a public body corporate and 
19 politic and an incorporated public instrumentality of the State. 
202. Membership. The committee consists of 7 individuals who must be residents of the 
21 State and are appointed as follows:
22 A. Two medical providers as defined in section 2422, subsection 4-C who have over 
23 the prior 2 years provided certification for the medical use of cannabis in accordance 
24 with the process described under section 2423-B, one appointed by the President of the 
25 Senate and one by the Speaker of the House;
26 B. Two registered caregivers as defined in section 2422, subsection 11, each of whom 
27 has held a registration for at least 2 consecutive years and has provided care for patients 
28 using at least 2 different modalities for introduction of cannabis into the body, one 
29 appointed by the President of the Senate and one by the Speaker of the House;
30 C. Two residents of the State who have been qualifying patients as defined in section 
31 2422, subsection 9 for at least 3 years and who have experience using at least 2 different 
32 modalities for introduction of cannabis into the body, one appointed by the President 
33 of the Senate and one by the Speaker of the House; and
34 D. One research professional employed by the University of Maine or other institution 
35 of higher education in the State, appointed by the Speaker of the House.
363. Term. Members are appointed to 4-year terms. If the appointing authority fails to 
37 make an appointment prior to the expiration of a member's term, that member continues to 
38 serve until the appointing authority makes an appointment for the remainder of that term. 4
5
6
7
8
9
10
11
12
Page 2 - 131LR1683(01)39 If a vacancy occurs prior to the expiration of a specified term, the appointing authority shall 
40 appoint an individual to serve only the remainder of that term.  
34. Duties. The duties of the committee include but are not limited to:
4 A. The creation of a grant application and review process for awarding grants under 
5 section 2430, subsection 5, including a process for data collection and reporting; 
6 B. The development and implementation of an annual 3rd-party-administered survey 
7 of medical use qualifying patients as defined in section 2422, subsection 9, caregivers 
8 as defined in section 2422, subsection 8-A, registered dispensaries as defined in section 
9 2422, subsection 6 and other stakeholders that provides usage data and other useful 
10 information to the public; and
11 C. The review of potential applications of complementary alternative medicines, 
12 including psilocybin, ketamine and 3, 4-methylenedioxymethamphetamine, MDMA. 
135. Compensation of members. Members are compensated in accordance with Title 5, 
14 section 12004-I, subsection 31-C. Stipends are to be paid out of the Medical Use of 
15 Cannabis Fund.
166. Report. The committee shall provide an annual report summarizing its activities by 
17 January 15, 2024 and annually thereafter to the joint standing committees of the Legislature 
18 having jurisdiction over health and human services matters and agriculture and forestry 
19 matters. 
207. Staffing. The Department of Administrative and Financial Services, Office of 
21 Cannabis Policy shall provide administrative support to the committee, including recording 
22 of minutes, meeting organization, facilitation of communication among members, 
23 conducting research and providing background information and data to the committee.
24Sec. 3.  Initial appointments.  Notwithstanding the Maine Revised Statutes, Title 
25 22, section 2700-F, subsection 3, in the Maine Cannabis Research Committee, the member 
26 appointed by the President of the Senate pursuant to Title 22, section 2700-F, subsection 2, 
27 paragraph A serves for 2 years. The members of the committee appointed by the Speaker 
28 of the House pursuant to Title 22, section 2700-F, subsection 2, paragraphs B and C serve 
29 for 2 years. All appointments thereafter must be for 4-year terms.
30SUMMARY
31 This bill establishes the Maine Cannabis Research Committee. The committee consists 
32 of 7 members, appointed by the President of the Senate and the Speaker of the House for 
33 4-year terms, and includes 2 medical providers, 2 registered caregivers, one research 
34 professional and 2 patients. The duties of the committee include the creation of a grant 
35 application and review process for awarding of medical cannabis funds, including a process 
36 for data collection and reporting, the implementation of an annual 3rd-party-administered 
37 survey for patients, providers and caregivers that provides data to the public, the review of 
38 potential applications of other complementary alternative medicines, including psilocybin, 
39 ketamine and 3, 4-methylenedioxymethamphetamine, MDMA. Members are entitled to 
40 compensation of $1,000 after the first 6 committee meetings in a calendar year and an 
41 additional $1,000 after 6 additional meetings in the same calendar year, to be paid out of 
42 the Medical Use of Cannabis Fund. The committee must provide an annual report 
43 summarizing its activities by January 15, 2024 and annually thereafter to the joint standing 1
2
31
32
33
34
35
36
37
38
39
40
41
42
43
Page 3 - 131LR1683(01)44 committees of the Legislature having jurisdiction over health and human services matters 
45 and agriculture and forestry matters. Staff from the Department of Administrative and 
46 Financial Services, Office of Cannabis Policy must provide administrative support to the 
47 committee, including recording of minutes, meeting organization, facilitation of 
48 communication among members, conducting research and providing background 
49 information and data to the committee.1
2
3
4
5
6
